Author

Diego Alonso‐López

Consejo Superior de Investigaciones CientíficasORCID 0000-0003-1015-9923Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alejandro RoselliD· 1 shared Belén Martínez-CastedoiD· 1 shared Charles SwantoniD· 1 shared Constantino Carlos Reyes‐AldasoroiD· 1 shared Cristina CuestaiD· 1 shared Diana Loa-Mesón· 1 shared Dirk Fennema GalparsoroiD· 1 shared Esther CastellanoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandro RosellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

RAS-PI3K signaling promotes myofibroblastic CAF identity and restrains an immunomodulatory stromal program

Cristina Cuesta, Marta Alcón Pérez, Rosa Ramírez Cota, Sara Coadour, Jie Zheng, Nicole Procel, Dirk Fennema Galparsoro, Alejandro Rosell, Diana Loa-Mesón, Belén Martínez-Castedo, Youssef Arafat, Héctor Sanz-Fraile, Vinothini Rajeeve, Diego Alonso‐López, Robert E. Hynds, , Esther Castellano

This study identifies RAS-PI3K signaling as a key regulator of myofibroblastic CAF identity and matrix competence in lung cancer, showing its role in restraining immunomodulatory stromal programs.

bioRxiv · Jan 20, 2025 · PreprintCancer Biology